Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Cullinan Therapeutics (NASDAQ:CGEM) through any online brokerage.
Other companies in Cullinan Therapeutics’s space includes: Bright Minds Biosciences (NASDAQ:DRUG), Monopar Therapeutics (NASDAQ:MNPR), Immuneering (NASDAQ:IMRX), Altimmune (NASDAQ:ALT) and Prothena Corp (NASDAQ:PRTA).
Cullinan Therapeutics has a consensus price target of $27.40.
The stock price for Cullinan Therapeutics (NASDAQ: CGEM) is $8.38 last updated November 12, 2025 at 7:19 PM EST.
There are no upcoming dividends for Cullinan Therapeutics.
Cullinan Therapeutics’s Q3 earnings are confirmed for Thursday, November 6, 2025.
There is no upcoming split for Cullinan Therapeutics.
Cullinan Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.